Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288948 · ClinicalTrials.gov registry record · NA
Binocular Amblyopia Treatment
A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03288948: Recruiting NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.
NCT03288948 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 120 participants, below the 161-participant average among 24 other Amblyopia trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03288948, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
Primary Outcome
ATS-HOTV for age 4-6.9 years or E-ETDRS for age 7-10.9 years
Conditions Studied
Interventions
- OTHER Binocular games for treatment of amblyopia
Study Locations (1)
Texas
- Retina Foundation of the Southwest - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-08-31 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT03288948 shows while recruiting
NCT03288948 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 161-participant average among 24 other Amblyopia trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Binocular games for treatment of amblyopia is the first listed.
NCT03288948 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03288948 about?
NCT03288948 is a clinical study titled "Binocular Amblyopia Treatment". To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
What is the current status of trial NCT03288948?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2017-08-31. Estimated completion is 2026-12-31.
What conditions does trial NCT03288948 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT03288948?
The interventions under investigation include: Binocular games for treatment of amblyopia (OTHER).
Who is sponsoring clinical trial NCT03288948?
This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03288948 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03288948's enrollment target sits among peer trials
120 13th of 24 higher than 12 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
RECRUITING · NA
-
Patch-free Occlusion Therapy
RECRUITING · NA
-
Amblyopia Treatment for Children Aged 8 to 12 Years
RECRUITING · NA
-
Novel Amblyopia Treatment With Virtual Reality Games
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI